Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Clinical trial NCT04485559 · RECRUITING

Trial details

NCT number: NCT04485559
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent World Health Organization (WHO) Grade II Glioma Low-grade Glioma High-Grade Glioma (HGG)

Start date: 2020-12-09
Primary completion: 2027-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.